132 related articles for article (PubMed ID: 3896641)
1. Clinical significance and nature of circulating immune complexes in melanoma patients.
Gupta RK; Morton DL
Contemp Top Immunobiol; 1985; 15():1-53. PubMed ID: 3896641
[No Abstract] [Full Text] [Related]
2. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
Wong JH; Gupta RK; Morton DL
Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
[TBL] [Abstract][Full Text] [Related]
3. Identification and isolation of melanoma-associated antigens with monoclonal antibodies.
Ross AH; Mitchell KF; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(4):413-21. PubMed ID: 6765324
[TBL] [Abstract][Full Text] [Related]
4. Melanoma antigens: immunological and biological characterization and clinical significance.
Herlyn M; Koprowski H
Annu Rev Immunol; 1988; 6():283-308. PubMed ID: 3289568
[No Abstract] [Full Text] [Related]
5. Workshop on monoclonal antibodies to human melanoma-associated antigens: findings of the Seattle group.
Hellström I; Brown JP; Hellström KE
Hybridoma; 1982; 1(4):399-402. PubMed ID: 6208136
[TBL] [Abstract][Full Text] [Related]
6. Multiple assay characterization of murine monoclonal antimelanoma antibodies.
Stuhlmiller GM; Borowitz MJ; Croker BP; Seigler HF
Hybridoma; 1982; 1(4):447-60. PubMed ID: 6208139
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes in human malignant melanoma.
D'Amelio R; Cooke B; Hobbs JR
Tumori; 1982 Dec; 68(6):469-72. PubMed ID: 7168010
[TBL] [Abstract][Full Text] [Related]
8. Higher cytolytic efficiency of an IgG2 alpha than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen.
Imai K; Pellegrino MA; Wilson BS; Ferrone S
Cell Immunol; 1982 Sep; 72(2):239-47. PubMed ID: 6185235
[No Abstract] [Full Text] [Related]
9. [Circulating immune complexes in the serum of tumor patients].
Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
Herlyn M; Steplewski Z; Atkinson BF; Ernst CS; Koprowski H
Hybridoma; 1982; 1(4):403-11. PubMed ID: 6765323
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of immune complexes, associated antigen, and antibody in cancer.
Salinas FA; Wee KH; Silver HK
Contemp Top Immunobiol; 1985; 15():55-109. PubMed ID: 3896644
[No Abstract] [Full Text] [Related]
12. Biochemical studies of immune complexes. II. Purification of immune complexes from sera of patients with malignant melanoma.
Quay SC; Murphy GF; Mihm MC
Clin Immunol Immunopathol; 1983 Mar; 26(3):318-26. PubMed ID: 6872347
[TBL] [Abstract][Full Text] [Related]
13. Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.
Harper JR; Bumol TF; Reisfeld RA
Hybridoma; 1982; 1(4):423-32. PubMed ID: 6208137
[TBL] [Abstract][Full Text] [Related]
14. Characterization of antigenic components of immune complexes isolated from a melanoma patient.
Cheng WC; Gupta RK; Morton DL
Immunol Invest; 1985 Aug; 14(4):367-78. PubMed ID: 4065936
[TBL] [Abstract][Full Text] [Related]
15. Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.
Esclamado RM; Gown AM; Vogel AM
Am J Surg; 1986 Oct; 152(4):376-85. PubMed ID: 3766867
[TBL] [Abstract][Full Text] [Related]
16. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
Chen ZJ; Yang H; Liu CC; Mittelman A; Ferrone S
Pigment Cell Res; 1992; Suppl 2():113-22. PubMed ID: 1409413
[No Abstract] [Full Text] [Related]
17. Monoclonal antibodies to human melanoma-associated antigens: an amplified enzyme-linked immunosorbent assay for the detection of antigen, antibody, and immune complexes.
Morgan AC; McIntyre RF
Cancer Res; 1983 Jul; 43(7):3155-9. PubMed ID: 6850625
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb.
Chen ZJ; Ferrone S
Ann N Y Acad Sci; 1993 Aug; 690():398-401. PubMed ID: 8368768
[No Abstract] [Full Text] [Related]
19. Short-term effects of i.v. injected murine 99MTc-F(ab')2 fragments of an anti-melanoma antibody (HMW-MAA 225.28 S) on haemato-immunological parameters in patients with melanoma.
Castello G; Mansi L; Leonardi E; Lastoria S; Melillo G
Int J Biol Markers; 1988; 3(2):140-4. PubMed ID: 3243979
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and pathogenetic implications of immune complexes in human cancer.
Salinas FA; Wee KH
Adv Immun Cancer Ther; 1986; 2():189-209. PubMed ID: 2962476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
